Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ARTHD

Arch Therapeutics (QB) (ARTHD)

Arch Therapeutics Inc (QB)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:ARTHD
일자시간출처헤드라인심볼기업
2024/05/2205:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/05/1005:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
2024/05/0705:36Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/04/0406:07Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/03/1905:29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/03/0206:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/03/0206:30Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
2024/02/2107:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ARTHDArch Therapeutics Inc (QB)
2024/02/1606:30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/02/0806:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/01/2302:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
2024/01/1306:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2024/01/1206:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/12/3006:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:ARTHDArch Therapeutics Inc (QB)
2023/12/1606:31Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/12/0906:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/11/2306:33Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/11/1606:47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/11/0920:50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/10/0606:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:ARTHDArch Therapeutics Inc (QB)
2023/10/0505:11Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/2806:12Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/1405:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/0906:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/0906:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/0805:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/0705:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/09/0205:30Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/08/2321:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ARTHDArch Therapeutics Inc (QB)
2023/08/2305:52Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:ARTHDArch Therapeutics Inc (QB)
 검색 관련기사 보기:USOTC:ARTHD